XML 13 R7.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flow from operating activities    
Net loss $ (14,957) $ (28,530)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:    
Depreciation expense 72 73
Amortization expense 34 65
Share-based compensation expense 2,447 3,540
Net foreign exchange impacts (25) 3,020
Other income, net (519) (969)
Change in operating assets and liabilities:    
Decrease in trade receivables 0 940
Decrease/(increase) in other current assets 931 (592)
(Increase)/decrease in R&D benefit receivable (209) 8,338
Decrease in other long-term assets 0 89
(Decrease)/increase in trade and other payables (2,949) 1,848
Increase in contract liabilities (404) (72)
Increase in operating lease liabilities (24) (59)
Net cash used in operations (15,603) (12,309)
Cash flow from investing activities    
Redemption of term deposits 74,427 25,683
Purchase of term deposits (64,427) (70,060)
Purchase of property, plant and equipment 0 (4)
Net cash provided by/(used in) investing activities 10,000 (44,381)
Cash flow from financing activities    
Proceeds from issue of ordinary shares 0 14
Net cash provided by financing activities 0 14
Decrease in cash and cash equivalents (5,603) (56,676)
Cash and cash equivalents at start of period 11,277 121,330
Effect of exchange rate fluctuations on cash and cash equivalents held (17) 232
Cash and cash equivalents, end of period 5,657 64,886
Supplemental disclosures of cash flow information:    
Tax Paid $ (88) $ (76)